Ovarian cancer molecular pathology.

Peer reviewe

In situ synchrotron radiation grazing incidence X-ray diffraction—A powerful technique for the characterization of solid-state ion-selective electrode surfaces

An in situ surface study of the iron chalcogenide glass membrane ion-selective electrode (ISE) in aqueous media has been undertaken using a tandem technique of mixed potential/synchrotron radiation grazing incidence X-ray diffraction (SR-GIXRD) and atomic force microscopy (AFM). This work has simultaneously monitored the mixed potential and in situ surface diffraction patterns of this crystalline glassy material, showing that the observed gradual shift of the electrode potential in the anodic direction is linked to the preferential dissolution of the GeSe (1 1 1), GeSe (1 0 1) and GeSe (1 4 1) and/or Sb2Se3 (0 1 3), Sb2Se3 (2 2 1) and Sb2Se3 (0 2 0) surfaces. Expectedly, these observations are internally consistent with preferential oxidative attack of the crystalline regions of the membrane comprising GeSe and/or Sb2Se3, as evidenced by AFM imaging of the electrode surface. Clearly, this work corroborates the results of previous ex situ surface studies on the iron chalcogenide glass ISE, whereby it was shown that alkaline saline solutions have a tendency to alter the surface chemistry and concomitant response characteristics of the ISE

/STRU^NI RAD UDK 616.65-006.04-097:577.112 The significance of TPSA, free to total PSA ratio and PSA density in prostate carcinoma diagnostics

Prostate-specific antigen (PSA) is the one of the most valuable tumor markers for the early detection and management of prostate carcinoma, but not an ideal one because of poor specificity in the case of prostatic hypertrophy and other benign conditions. In order to overcome this drawback some other parameters as is free to total ratio (F/T) PSA and PSA density (PSAD) are introduced. It has been investigated in 60 patients, 18 of them are proved to be found prostate cancer and other 42 were identified as benign prostatic hyperplasia. Patients with CaP had TPSA median of 11.4 ng/ml and the others with benign prostatic hyperplasia (BPH) had 6.9 ng/ml. In these two groups there was statistical significant difference (p 0.01). By receiver operating characteristics curve (ROC) estimated cutoff for TPSA was 4.0 ng/ml with 95 % sensitivity, 30 % specificity and area covered by ROC was in amount of 0.76. Median F/T ratio for patients with prostate cancer was 0.10, and for benign prostatic hyperplasia patients it was 0.25.For these values there is also statistical difference (p). Using ROC cutoff for F/T PSA was determined at the value of 0.18 with sensitivity 95%, specificity 80 % and area under the curve (AUC) 0.93. Median for PSAD in the group with CaP was 0.38 and in the BPH group was 0.16. There was statistical significance within those two groups. In conclusion F/T PSA, PSAD and TPSA are valuable tumor markers in distinguishing patients with CaP ant those without with modestly raised TPSA. Also F/T PSA showed up as better marker than TPSA and PSAD in investigated group of patients. Key words: prostate carcinoma, benign prostatic hyperplasia, prostate specific antigen, PSA density, free to total PSA ratio rezim

kidney parenchimal and collecting tract neoplasia

Border line cases and diagnostic doubts in definitio

Bilateral renal cell carcinoma with bilateral synchronous adrenal gland metastases – a case report

The authors reported a case of a 52-year-old patient with bilateral synchronous renal cell carcinoma synchronously disseminated in adrenal glands is presented. The patient underwent surgical treatment: radical nephrectomy on the right side, bilateral adrenectomie on the right and partial nephrectomy on the left side. Five years after surgery, patient is in complete remissio